Difference between revisions of "Template:Article of the week"

From LIMSWiki
Jump to navigationJump to search
(Updated article of the week text)
(24 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''"[[Journal:Next steps for access to safe, secure DNA synthesis|Next steps for access to safe, secure DNA synthesis]]"'''
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Anx1 WHO 2020 2020.5.png|240px]]</div>
'''"[[Journal:Laboratory testing for coronavirus disease (COVID-19) in suspected human cases|Laboratory testing for coronavirus disease (COVID-19) in suspected human cases]]"'''


The [[DNA synthesis]] industry has, since the invention of gene-length synthesis, worked proactively to ensure synthesis is carried out securely and safely. Informed by guidance from the U.S. government, several of these companies have collaborated over the last decade to produce a set of best practices for customer and sequence screening prior to manufacture. Taken together, these practices ensure that synthetic DNA is used to advance research that is designed and intended for public benefit. With increasing scale in the industry and expanding capability in the synthetic biology toolset, it is worth revisiting current practices to evaluate additional measures to ensure the continued safety and wide availability of DNA synthesis. Here we encourage specific steps, in part derived from successes in the [[cybersecurity]] community, that can ensure synthesis screening systems stay well ahead of emerging challenges, to continue to enable responsible research advances. [[Artificial gene synthesis|Gene synthesis]] companies, science and technology funders, policymakers, and the scientific community as a whole have a shared duty to continue to minimize risk and maximize the safety and security of DNA synthesis to further power world-changing developments in advanced biological manufacturing, agriculture, drug development, healthcare, and energy. ('''[[Journal:Next steps for access to safe, secure DNA synthesis|Full article...]]''')<br />
This document provides interim guidance to [[Laboratory|laboratories]] and stakeholders involved in [[COVID-19]] virus laboratory testing of patients. It is based in part on the interim guidance on laboratory testing for [[Middle East respiratory syndrome]] (MERS) coronavirus. [[Information]] on human [[infection]] with the COVID-19 virus is evolving and the [[World Health Organization]] (WHO) continues to monitor developments and revise recommendations as necessary. This document will be revised as new information becomes available. Feedback is welcome and can be sent to WHElab@who.int. The virus has now been named SARS-CoV-2 by the International Committee of Taxonomy of Viruses (ICTV)(2). This virus can cause the disease named coronavirus disease 2019 (COVID-19). WHO refers to the virus as COVID-19 virus in its current documentation. ('''[[Journal:A security review of local government using NIST CSF: A case study|Full article...]]''')<br />
<br />
<br />
''Recently featured'':
''Recently featured'':
: ▪ [[Journal:Japan Aerospace Exploration Agency’s public-health monitoring and analysis platform: A satellite-derived environmental information system supporting epidemiological study|Japan Aerospace Exploration Agency’s public-health monitoring and analysis platform: A satellite-derived environmental information system supporting epidemiological study]]
: ▪ [[Journal:One tool to find them all: A case of data integration and querying in a distributed LIMS platform|One tool to find them all: A case of data integration and querying in a distributed LIMS platform]]
: ▪ [[Journal:Smart grids and ethics: A case study|Smart grids and ethics: A case study]]
: ▪ [[Journal:What is the "source" of open-source hardware?|What is the "source" of open-source hardware?]]
: ▪ [[Journal:Heart failure and healthcare informatics|Heart failure and healthcare informatics]]
: ▪ [[Journal:From command-line bioinformatics to bioGUI|From command-line bioinformatics to bioGUI]]

Revision as of 15:46, 23 March 2020

Anx1 WHO 2020 2020.5.png

"Laboratory testing for coronavirus disease (COVID-19) in suspected human cases"

This document provides interim guidance to laboratories and stakeholders involved in COVID-19 virus laboratory testing of patients. It is based in part on the interim guidance on laboratory testing for Middle East respiratory syndrome (MERS) coronavirus. Information on human infection with the COVID-19 virus is evolving and the World Health Organization (WHO) continues to monitor developments and revise recommendations as necessary. This document will be revised as new information becomes available. Feedback is welcome and can be sent to WHElab@who.int. The virus has now been named SARS-CoV-2 by the International Committee of Taxonomy of Viruses (ICTV)(2). This virus can cause the disease named coronavirus disease 2019 (COVID-19). WHO refers to the virus as COVID-19 virus in its current documentation. (Full article...)

Recently featured:

▪ One tool to find them all: A case of data integration and querying in a distributed LIMS platform
▪ What is the "source" of open-source hardware?
▪ From command-line bioinformatics to bioGUI
Retrieved from "https://www.limswiki.org/index.php?title=Template:Article_of_the_week&oldid=38742"